Furthermore, we show that a reduction in MCAM gene expression is associated with the increased methylation of the MCAM promoter in tumour tissue, an epigenetic modification that is known to repress gene expression and highlighted as a key regulator of breast cancer progression (Pasculli et al., 2018). The gene discussed is MCAM; the disease is neoplasm.